类固醇生成通路遗传易感性与局限性前列腺癌进展至不可治愈阶段的风险
研究基于多中心前瞻性PROCURE队列1926例局限性前列腺癌患者,分析10个类固醇生成基因上22个单核苷酸多态性及15种激素水平与生化复发、转移、去势抵抗和前列腺癌特异性死亡的关系。中位随访9.8年,CYP17A1、SRD5A2、CYP19A1和CYP1B1变异与生化复发无生存期名义相关,SRD5A2、HSD17B2和CYP1B1与致死性疾病相关,累积关联可较单个SNP更准确预测转移/去势抵抗和致命结局。
要点
- 类固醇生成通路胚系变异与前列腺切除时循环激素水平名义相关。
- SRD5A2、HSD17B2和CYP1B1变异与致死性疾病相关。
- 多个标记累积关联较单个SNP更准确预测转移/去势抵抗和致命结局。
核心结论
- 宿主遗传变异与手术时循环激素水平相关,并对疾病进展具有潜在临床意义。
- 这些标记是开发非侵入性策略以细化局限性进展至晚期前列腺癌遗传风险分层的一步。
研究设计与样本
- 多中心前瞻性PROCURE队列,纳入1926例局限性前列腺癌患者。
- 分析10个类固醇生成基因上22个单核苷酸多态性与15种激素水平、生化复发无生存期、转移、去势抵抗性前列腺癌和前列腺癌特异性死亡的关系。
主要发现
- 中位随访9.8年,CYP17A1、SRD5A2、CYP19A1和CYP1B1变异与生化复发无生存期名义相关。
- SRD5A2、HSD17B2和CYP1B1变异与致死性疾病相关。
- 这些标记的累积关联较单个SNP更准确预测转移/去势抵抗性前列腺癌时间和致命结局。
- CYP17A1、SRD5A1和SRD5A2启动子变异改变细胞模型转录活性,CYP1B1变异与原发性肿瘤蛋白表达降低相关,可能因蛋白酶体降解增强。
临床怎么用
- 类固醇生成通路胚系标记可用于细化局限性前列腺癌进展风险的遗传分层。
- 累积多个标记的关联较单个SNP更能预测转移/去势抵抗和致命结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The heterogeneity of prostate cancer (PCa) poses a significant challenge to accurately predict those who will progress to lethal stage. Although RNA signatures and somatic DNA alterations can be used to predict clinical outcomes in men with localized PCa, incorporating germline markers may further enhance early prediction of progression to incurable disease. MATERIALS AND METHODS: We examined germline markers in steroidogenic pathways in the multi-institutional prospective PROCURE cohort of 1926 patients with localized PCa. The association between 22 single-nucleotide polymorphisms across 10 steroidogenic genes and 15 hormone levels, biochemical recurrence-free survival, development of metastasis, castration-resistance prostate cancer (CRPC), and PCa-specific mortality was assessed along with their potential functional implications. RESULTS: Thirteen markers were nominally associated with circulating hormone levels at prostatectomy. At a median follow-up of 9.8 years, variants in CYP17A1, SRD5A2, CYP19A1, and CYP1B1 showed nominal associations with biochemical recurrence-free survival, while those located in SRD5A2, HSD17B2, and CYP1B1 were associated with lethal disease. Cumulative associations of these markers predicted time to metastasis/castration-resistance prostate cancer and fatal outcomes more accurately than individual single-nucleotide polymorphism. Mechanistically, promoter variants in CYP17A1, SRD5A1, and SRD5A2 altered transcriptional activity in cell models, while a CYP1B1 variant was linked to reduced protein expression in primary tumors, likely due to enhanced proteasomal degradation. CONCLUSIONS: Our findings support an association between host genetic variation and circulating hormone levels at surgery, with potential clinical implications for disease progression. These markers represent a step toward the development of noninvasive strategies to refine inherited risk stratification for progression from localized to advanced PCa.
引用
- Lévesque E, Lacombe L, Saad F, et al. Inherited Predisposition in Steroidogenic Pathways and Risk of Transition to Incurable Prostate Cancer in Men With Localized Disease. J Urol. 2026. PMID: 42821636. doi:10.1097/JU.0000000000005334
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。